BONUS!!! Download part of PassTorrent ALS-Con-201 dumps for free: https://drive.google.com/open?id=1I4z9wm5QRkoZz3XExv9xdNbjkM2Rii99
ALS-Con-201 also offers free demos, allowing users to test the quality and suitability of the ALS-Con-201 exam dumps before purchasing. The demo provides access to a limited portion of the material, providing users with a better understanding of the content. Additionally, ALS-Con-201 provides three months of free updates to ensure that candidates have access to the latest questions.
| Section | Weight | Objectives |
|---|---|---|
| Topic 1: Life Sciences Industry Overview and Salesforce Agentforce for Life Sciences | 15% | - Understand Life Sciences industry processes (pharmaceutical, biotech, medical device) - Explain key regulatory compliance requirements (FDA, GxP, HIPAA) - Describe how Agentforce applies to Life Sciences use cases |
| Topic 2: Testing, Deployment, and Enablement | 20% | - Create documentation for regulated environments - Plan and execute testing strategies for Life Sciences solutions - Develop training materials for Life Sciences users - Deploy Agentforce solutions following validation requirements - Establish support processes for post-production compliance |
| Topic 3: Discovery and Requirements Gathering | 20% | - Assess data quality and integration needs - Map business processes to Salesforce Agentforce capabilities - Identify stakeholder requirements for Life Sciences implementations - Document functional and technical requirements |
| Topic 4: Compliance and Security | 20% | - Implement data security for HIPAA compliance - Set up data partitioning for multi-tenant pharmaceutical environments - Configure audit trails and tracking for FDA requirements - Apply Field Audit Trail for regulated data |
| Topic 5: Solution Design and Configuration | 25% | - Design Agentforce solutions for Life Sciences scenarios - Implement Agentforce AI agents for clinical trial support - Configure Salesforce Health Cloud for Life Sciences - Build automation flows for compliance workflows - Design integration with external Life Sciences systems |
>> Latest ALS-Con-201 Exam Review <<
If you want to buy our ALS-Con-201 training engine, you must ensure that you have credit card. We do not support deposit card and debit card to pay for the ALS-Con-201 exam questions. Also, the system will deduct the relevant money. If you find that you need to pay extra money for the ALS-Con-201 Study Materials, please check whether you choose extra products or there is intellectual property tax. All in all, you will receive our ALS-Con-201 learning guide via email in a few minutes.
NEW QUESTION # 36
Choose 1 option.
Cumulus Pharma has a compliance policy regarding "Off-Label" discussions. The company's Agentforce Life Sciences Consultant needs to configure the Agentforce Life Sciences visit experience to explicitly control whether field sales reps are allowed to discuss products for indications that have not yet been approved.
Which setting within the Admin Console handles this capability?
Answer: C
Explanation:
The correct answer is B because off-label control in the visit experience is tied to product detailing behavior. In life sciences commercial engagement, product detailing governs what products, messages, indications, and approved content can be discussed or shown during a visit. Salesforce Trailhead describes Life Sciences Cloud content visibility as being filtered by territory, product assignment, and account restrictions to prevent off-label or noncompliant sharing. This aligns most closely with Visit Settings > Product Detailing Settings, because that is the visit configuration area where product discussion and detailing behavior is controlled.
The question asks where the consultant should configure whether reps are allowed to discuss products for unapproved indications. That is not a generic compliance switch; it is a visit-detailing control connected to product and indication behavior in the field engagement workflow. Product Detailing Settings are therefore the correct place to enforce whether off-label discussion is permitted, warned, or restricted according to company policy.
Option A is incorrect because "Compliance Settings > Off-Label Validation" is not the standard configuration path presented in the available options for the Life Sciences visit experience. Option C is also incorrect because Restricted Products would control whether products are available or restricted, but the scenario is specifically about discussion of unapproved indications during product detailing. Therefore, the consultant should use Visit Settings > Product Detailing Settings.
=========
NEW QUESTION # 37
Choose 1 option.
Cumulus Pharma requires a unified view for field sales reps to monitor the full lifecycle of their sample stock. Specifically, reps must be able to view their current batch assignments, track received inventory, monitor disbursements to Healthcare Providers (HCPs), and view the status of recent transfers or returns in a single interface without navigating to multiple object tabs. The Agentforce Life Sciences Consultant must ensure this comprehensive view is available to reps in the Agentforce Life Sciences mobile app.
Which step should the consultant configure to meet this requirement?
Answer: A
Explanation:
The correct answer is C because Salesforce Life Sciences Sample Inventory Management is intended to provide a unified view of sample-related inventory activity. Salesforce documentation describes Sample Inventory Management as providing a unified view of transactions, shipments, inventory counts, and assigned batches, helping users stay on top of items requiring attention. This directly matches the requirement for reps to monitor batch assignments, received inventory, disbursements, transfers, and returns from one experience rather than navigating across multiple object tabs.
To make that experience available in the Agentforce Life Sciences mobile app, the consultant should expose the Sample Inventory Management dashboard through the user's navigation configuration. Adding it to Navigation Items ensures the field sales rep profile can access the dashboard from the mobile app. This is better than building a custom report type because the standard dashboard is purpose-built for Life Sciences sample inventory workflows and already aligns with the sample inventory data model and operations.
Option A is not the best answer because a custom report chart would be less functional than the standard inventory dashboard and would not provide the operational interface reps need. Option B is also incomplete. The Inventory Operations Timeline is useful for viewing transaction history, and Salesforce describes it as an overview of transactions and product requests in chronological order, but it does not provide the full dashboard experience for assigned batches, inventory counts, shipments, and operational status.
NEW QUESTION # 38
Choose 1 option.
A sales director at Cumulus Pharma requires the field team to capture shifts in sentiment and competitive threats during interactions with Healthcare Providers (HCPs). These observations must be structured to help the organization identify commercial risks early and deploy mitigation strategies.
Which Agentforce Life Sciences for Customer Engagement feature should an Agentforce Life Sciences Consultant configure?
Answer: C
Explanation:
The correct answer is C because the scenario is asking for structured capture of field observations, sentiment changes, and competitive intelligence gathered during HCP interactions. Salesforce Life Sciences Cloud includes Medical Insights for capturing, analyzing, and sharing insights with medical, R&D, and commercial teams. Salesforce's Life Sciences Cloud pharma materials describe the capability as helping teams detect, capture, analyze, and share medical insights across R&D and commercial teams, while Salesforce Help also provides setup guidance for Medical Insights in Life Sciences Cloud.
Medical Insights is the best fit because the business requirement is not merely to log a question from an HCP. It is to capture structured observations that can reveal commercial risks, such as competitor activity, sentiment shifts, or emerging concerns. These insights can then support early risk identification and mitigation planning.
Option A is incorrect because Medical Inquiries are used to capture, manage, and respond to critical questions from HCPs, including formal inquiries that may require medical information handling. Salesforce describes Medical Inquiries as a way to capture, manage, and respond to critical questions from HCPs. That is different from capturing strategic field insights. Option B is also incorrect because Account Ratings help prioritize or segment accounts, but they are not the structured feature for recording competitive intelligence and sentiment observations. Therefore, Medical Insights is the correct feature.
=========
NEW QUESTION # 39
Choose 1 option.
Cumulus Pharma wants to allocate samples from a specific production batch to a field sales rep's inventory so the company can track the remaining quantity by batch and automatically update inventory during disbursements.
Which action fulfills this requirement?
Answer: B
Explanation:
Option C is correct because Product Batch Item is the Salesforce Life Sciences Cloud record that connects a production batch to a specific product inventory location or user inventory context. Salesforce Help describes creating Product Batch Items for sample inventory and states that a product batch item establishes the relationship between the Product, Life Science Marketable Product, Production Batch, Product Batch Item, Location, and User. This directly matches the scenario: Cumulus Pharma needs to allocate samples from a specific production batch to a field sales rep's inventory and track remaining quantity at the batch level.
The ProductBatchItem object also includes the RemainingQuantity field, which supports the requirement to track remaining quantity by batch. Salesforce's Life Sciences Cloud Developer Guide documents ProductBatchItem and identifies RemainingQuantity as a field on the object.
Option A is incorrect because simply assigning a Production Batch to the Life Sciences Marketable Product does not allocate batch-specific stock to a rep's inventory. Visit submissions can update inventory, but the batch allocation must already be represented correctly. Option B is also incorrect because updating Quantity on Hand on Product Item only changes general product inventory at a location. It does not establish the production-batch relationship needed for batch-level tracking. Therefore, the consultant should create a Product Batch Item, associate it to the rep's Product Item, mark it Active, and enter the Remaining Quantity.
=========
NEW QUESTION # 40
Choose 1 option.
Cumulus Pharma uses the Medical Insights feature in Agentforce Life Sciences for Customer Engagement to record insights from engagements with Healthcare Providers (HCPs). The company's customer engagement analytics team is reporting duplicate upvotes made by field sales reps and an inability to see the total count of upvotes on the Medical Insights record.
Which out-of-the-box configuration should an Agentforce Life Sciences Consultant use to address the upvote issues?
Answer: A
Explanation:
Option C is correct because Medical Insight upvotes are handled through the UserReaction object and related out-of-the-box logic. Salesforce's Life Sciences Cloud Developer Guide states that UserReaction represents a user's reaction to a medical insight, such as an upvote or downvote, and that these reactions are used to identify trending insights. This directly supports the scenario because the problem involves duplicate upvotes and the inability to see total upvote counts on Medical Insight records.
Salesforce's MedicalInsight object documentation also references fields related to ranking and upvotes, including a default rank determined based on linked insights and their upvotes. This confirms that upvote behavior is part of the standard Medical Insights data model rather than something that should be rebuilt manually.
Option A is not the best answer because MedicalInsightValidationHandler sounds focused on validating Medical Insight records generally, not specifically managing user reactions, duplicate reactions, or upvote counts. Option B is also not preferred because custom validation rules and a new roll-up summary field would duplicate behavior that Salesforce provides through the Medical Insights user-reaction framework. The requirement asks for the out-of-the-box configuration, so the consultant should activate the UserReactionMedicalInsightHandler to manage upvote reactions consistently and support the total-count behavior.
=========
NEW QUESTION # 41
......
Three versions of ALS-Con-201 study materials are available. We can meet your different needs. ALS-Con-201 PDF version is printable and you can print it into hard one, and you can take them anywhere. ALS-Con-201Online test engine supports all web browsers, and you can have a brief review before your next practicing. ALS-Con-201 Soft test engine can stimulate the real exam environment, and it can help you know the process of the real exam, this version will relieve your nerves. Just have a try, and there is always a suitable version for you!
ALS-Con-201 Reliable Test Vce: https://www.passtorrent.com/ALS-Con-201-latest-torrent.html
P.S. Free & New ALS-Con-201 dumps are available on Google Drive shared by PassTorrent: https://drive.google.com/open?id=1I4z9wm5QRkoZz3XExv9xdNbjkM2Rii99